Company · CIK 1764791
Orphazyme A/S
| CIK | 1764791 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | G7 |
| Business address | Denmark |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-03-02 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-260283 | 2021-10-15 | 2022-03-23 | 4 | |
| 333-248607 | 2020-09-04 | 2020-09-29 | 8 |
Filings
13| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2022-03-23 | EFFECTDeclared effective | 333-260283 | 9999999995-22-000701 |
| 2021-11-04 | 424B5Shelf takedown | 333-260283 | 0001193125-21-319361 |
| 2021-10-22 | EFFECTDeclared effective | 333-260283 | 9999999995-21-004014 |
| 2021-10-15 | F-3Shelf registered | 333-260283 | 0001193125-21-300042 |
| 2020-09-29 | 424B4Final prospectus | 333-248607 | 0001193125-20-257890 |
| 2020-09-28 | EFFECTDeclared effective | 333-248607 | 9999999995-20-002592 |
| 2020-09-28 | F-1/AAmendment | 333-248607 | 0001193125-20-256234 |
| 2020-09-25 | F-1/AAmendment | 333-248607 | 0001193125-20-254540 |
| 2020-09-24 | F-1/AAmendment | 333-248607 | 0001193125-20-252847 |
| 2020-09-23 | F-1/AAmendment | 333-248607 | 0001193125-20-252088 |
| 2020-09-21 | F-1/AAmendment | 333-248607 | 0001193125-20-249547 |
| 2020-09-04 | F-1Registration filed | 333-248607 | 0001193125-20-239902 |
| 2020-06-30 | DRSDraft made public | 377-03262 | 0000950123-20-006578 |